These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients. Dzavík V, Burton JR, Kee C, Teo KK, Ignaszewski A, Lucas AR, Tymchak WJ. Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277 [Abstract] [Full Text] [Related]
28. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction. Li JL, Xue H, Wang BS, Zhang HY, Yin LH, Shun WD, Wu Y, Wang LX. Med Sci Monit; 2007 Jun; 13(6):CR270-74. PubMed ID: 17534233 [Abstract] [Full Text] [Related]
29. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G. Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323 [Abstract] [Full Text] [Related]
34. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. Lehmann A, Kiessling AH, Isgro F, Zeitler C, Thaler E, Boldt J. Eur J Anaesthesiol; 2008 Mar; 25(3):224-9. PubMed ID: 17892614 [Abstract] [Full Text] [Related]
35. Importance of levosimendan on right ventricular function in patients with biventricular heart failure. Erdem A, Birhan Yilmaz M. Crit Care Med; 2010 May; 38(5):1389-90; author reply 1390-1. PubMed ID: 20404640 [No Abstract] [Full Text] [Related]
36. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study. García-González MJ, Jorge-Pérez P, Jiménez-Sosa A, Acea AB, Lacalzada Almeida JB, Ferrer Hita JJ. Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786 [Abstract] [Full Text] [Related]
37. Safety and effectiveness of levosimendan in patients with predominant right heart failure. Poelzl G, Zwick RH, Grander W, Metzler B, Jonetzko P, Frick M, Ulmer H, Pachinger O, Roithinger FX. Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157 [Abstract] [Full Text] [Related]
38. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Jolly S, Newton G, Horlick E, Seidelin PH, Ross HJ, Husain M, Dzavik V. Am J Cardiol; 2005 Dec 15; 96(12):1617-20. PubMed ID: 16360345 [Abstract] [Full Text] [Related]
39. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases. García-González MJ, Domínguez-Rodríguez A, Ferrer-Hita JJ. J Clin Pharmacol; 2005 Jun 15; 45(6):704-8. PubMed ID: 15901754 [No Abstract] [Full Text] [Related]
40. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction]. Arias EA, González-Chon O, García-López SM, Chacón MA, Noriega-Iriondo F, Vega RE, Chávez-Tapia NC. Arch Cardiol Mex; 2005 Jun 15; 75(3):260-6. PubMed ID: 16294814 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]